iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting

MLA

Jeffrey S Miller, et al. “IPSC-Derived Natural Killer Cells Expressing the FcγR Fusion CD64/16A Can Be Armed with Antibodies for Multitumor Antigen Targeting.” Journal for ImmunoTherapy of Cancer, vol. 11, no. 12, Dec. 2023. EBSCOhost, https://doi.org/10.1136/jitc-2023-007280.

APA

Jeffrey S Miller, Martin Hosking, Ryan Bjordahl, Bahram Valamehr, Soheila Shirinbak, Zachary Davis, Bryan Hancock, Bruce Walcheck, Kristin M Snyder, Kate J Dixon, Geoffrey Hart, Melissa Khaw, Anders Matson, & Jianming Wu. (2023). iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting. Journal for ImmunoTherapy of Cancer, 11(12). https://doi.org/10.1136/jitc-2023-007280

Chicago

Jeffrey S Miller, Martin Hosking, Ryan Bjordahl, Bahram Valamehr, Soheila Shirinbak, Zachary Davis, Bryan Hancock, et al. 2023. “IPSC-Derived Natural Killer Cells Expressing the FcγR Fusion CD64/16A Can Be Armed with Antibodies for Multitumor Antigen Targeting.” Journal for ImmunoTherapy of Cancer 11 (12). doi:10.1136/jitc-2023-007280.